Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Innoviva, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
INVA
Nasdaq
2834
www.inva.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Innoviva, Inc.
Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
- Feb 6th, 2025 12:00 pm
Innoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five years
- Dec 25th, 2024 10:09 am
Innoviva enters distribution, license agreement with Basilea for Zevtera
- Dec 17th, 2024 12:25 pm
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)
- Dec 16th, 2024 12:00 pm
Innoviva to Participate in the Citi 2024 Global Healthcare Conference
- Nov 26th, 2024 12:00 pm
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity
- Nov 22nd, 2024 4:14 am
Innoviva to Participate in the UBS Global Healthcare Conference
- Nov 12th, 2024 9:05 pm
Innoviva Third Quarter 2024 Earnings: EPS: US$0.019 (vs US$1.26 in 3Q 2023)
- Nov 8th, 2024 10:06 am
Innoviva: Q3 Earnings Snapshot
- Nov 6th, 2024 10:23 pm
Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
- Nov 6th, 2024 9:05 pm
Innoviva, Inc.'s (NASDAQ:INVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
- Sep 30th, 2024 10:08 am
Innoviva to Participate in Upcoming Investor Conferences
- Sep 4th, 2024 11:00 am
Innoviva: Q2 Earnings Snapshot
- Jul 31st, 2024 9:51 pm
Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
- Jul 31st, 2024 8:05 pm
Innoviva (NASDAQ:INVA) shareholders have earned a 36% return over the last year
- Jul 17th, 2024 11:03 am
The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024
- Jul 9th, 2024 5:30 pm
3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge
- Jun 27th, 2024 12:00 pm
Apple downgraded, Kroger upgraded: Wall Street's top analyst calls
- Jun 18th, 2024 1:51 pm
Calculating The Fair Value Of Innoviva, Inc. (NASDAQ:INVA)
- Jun 6th, 2024 12:39 pm
Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Jun 3rd, 2024 11:00 am
Scroll